Ex-OpenAI researcher raises $200M for AI drug discovery at $2B valuation
Miles Wang, an OpenAI researcher focused on AI-accelerated biological discovery, is leaving to launch a drug discovery startup at a $2B valuation. On the same day, Chai Discovery announced a $400M round at a $3.8B valuation.
